These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 27665576)
1. Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation. Sun HY; Lin CC; Tsai PJ; Tsai WJ; Lee JC; Tsao CW; Cheng PN; Wu IC; Chiu YC; Chang TT; Young KC Cell Microbiol; 2017 Apr; 19(4):. PubMed ID: 27665576 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis. Tanaka N; Moriya K; Kiyosawa K; Koike K; Aoyama T Int J Cancer; 2008 Jan; 122(1):124-31. PubMed ID: 17764115 [TBL] [Abstract][Full Text] [Related]
3. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III. Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516 [TBL] [Abstract][Full Text] [Related]
4. Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections. Patra T; Sasaki R; Meyer K; Ray RB; Ray R J Virol; 2019 Sep; 93(18):. PubMed ID: 31243135 [TBL] [Abstract][Full Text] [Related]
5. Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase. Ziouzenkova O; Perrey S; Asatryan L; Hwang J; MacNaul KL; Moller DE; Rader DJ; Sevanian A; Zechner R; Hoefler G; Plutzky J Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2730-5. PubMed ID: 12606719 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus induced up-regulation of microRNA-27: a novel mechanism for hepatic steatosis. Singaravelu R; Chen R; Lyn RK; Jones DM; O'Hara S; Rouleau Y; Cheng J; Srinivasan P; Nasheri N; Russell RS; Tyrrell DL; Pezacki JP Hepatology; 2014 Jan; 59(1):98-108. PubMed ID: 23897856 [TBL] [Abstract][Full Text] [Related]
7. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators. Duncan JG; Bharadwaj KG; Fong JL; Mitra R; Sambandam N; Courtois MR; Lavine KJ; Goldberg IJ; Kelly DP Circulation; 2010 Jan; 121(3):426-35. PubMed ID: 20065164 [TBL] [Abstract][Full Text] [Related]
8. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection. Andréo U; Maillard P; Kalinina O; Walic M; Meurs E; Martinot M; Marcellin P; Budkowska A Cell Microbiol; 2007 Oct; 9(10):2445-56. PubMed ID: 17517063 [TBL] [Abstract][Full Text] [Related]
9. Activation of the oncogenic miR-21-5p promotes HCV replication and steatosis induced by the viral core 3a protein. Clément S; Sobolewski C; Gomes D; Rojas A; Goossens N; Conzelmann S; Calo N; Negro F; Foti M Liver Int; 2019 Jul; 39(7):1226-1236. PubMed ID: 30938910 [TBL] [Abstract][Full Text] [Related]
10. Arylacetamide deacetylase: a novel host factor with important roles in the lipolysis of cellular triacylglycerol stores, VLDL assembly and HCV production. Nourbakhsh M; Douglas DN; Pu CH; Lewis JT; Kawahara T; Lisboa LF; Wei E; Asthana S; Quiroga AD; Law LM; Chen C; Addison WR; Nelson R; Houghton M; Lehner R; Kneteman NM J Hepatol; 2013 Aug; 59(2):336-43. PubMed ID: 23542347 [TBL] [Abstract][Full Text] [Related]
11. Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry. Maillard P; Walic M; Meuleman P; Roohvand F; Huby T; Le Goff W; Leroux-Roels G; Pécheur EI; Budkowska A PLoS One; 2011; 6(10):e26637. PubMed ID: 22039521 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. Moriya K; Yotsuyanagi H; Shintani Y; Fujie H; Ishibashi K; Matsuura Y; Miyamura T; Koike K J Gen Virol; 1997 Jul; 78 ( Pt 7)():1527-31. PubMed ID: 9225025 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway. Mukherjee A; Di Bisceglie AM; Ray RB J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644 [TBL] [Abstract][Full Text] [Related]
14. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity? Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049 [TBL] [Abstract][Full Text] [Related]
15. [Possible mechanisms of hepatitis C virus-related hepatocarcinogenesis]. Tanaka N; Aoyama T Nihon Rinsho; 2004 Nov; 62(11):2137-44. PubMed ID: 15552900 [TBL] [Abstract][Full Text] [Related]
16. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. Tanaka N; Moriya K; Kiyosawa K; Koike K; Gonzalez FJ; Aoyama T J Clin Invest; 2008 Feb; 118(2):683-94. PubMed ID: 18188449 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A. Cheng Y; Dharancy S; Malapel M; Desreumaux P World J Gastroenterol; 2005 Dec; 11(48):7591-6. PubMed ID: 16437683 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C Virus. Gondar V; Molina-Jiménez F; Hishiki T; García-Buey L; Koutsoudakis G; Shimotohno K; Benedicto I; Majano PL J Virol; 2015 Oct; 89(19):9962-73. PubMed ID: 26202245 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus core protein-induced miR-93-5p up-regulation inhibits interferon signaling pathway by targeting IFNAR1. He CL; Liu M; Tan ZX; Hu YJ; Zhang QY; Kuang XM; Kong WL; Mao Q World J Gastroenterol; 2018 Jan; 24(2):226-236. PubMed ID: 29375208 [TBL] [Abstract][Full Text] [Related]